Clinical Trial Update: Safety and Efficacy of Itacitinib in Adults With Systemic Sclerosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating the safety and efficacy of itacitinib in adults with systemic sclerosis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• Itacitinib (itacitinib)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Systemic Sclerosis | Phase 2 | Status: RECRUITING